The Indian pharmaceutical landscape is currently defined by a paradox: while the demand for medicine is at an all-time high, the cost of maintaining a fully integrated manufacturing facility has never been more taxing. For emerging brands and established players alike, the question of profitability isn’t just about sales—it’s about capital efficiency.
